Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
278
datasets available to search
ShareScore release 0.9.0
Dataset results
278 results for “oligonucleotides”
Regulatory RNA inhibition in human phagocytes using cell-penetrating PNA oligonucleotides
GEO Series GSE152740. Homo sapiens. 12 samples. Type: Expression profiling by high throughput sequencing.
Dnm2 downregulation by antisense oligonucleotide (ASO1) injections rescue a murine model of recessive centronuclear myopathy (Bin1mck-/-)
GEO Series GSE160077. Mus musculus. 16 samples. Type: Expression profiling by high throughput sequencing.
A deep intronic splice-altering AIRE variant causes APECED syndrome through antisense oligonucleotide-targetable pseudoexon inclusion
GEO Series GSE254003. Homo sapiens. 12 samples. Type: Expression profiling by high throughput sequencing.
Detection of Cancer with Serum miRNAs on an Oligonucleotide Microarray
GEO Series GSE16512. Homo sapiens. 36 samples. Type: Non-coding RNA profiling by array.
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide
GEO Series GSE83549. Homo sapiens. 12 samples. Type: Expression profiling by high throughput sequencing.
PMP22 antisense oligonucleotides reverse clinical, pathological, and molecular features of Charcot-Marie-Tooth disease type 1A
GEO Series GSE103799. Mus musculus. 43 samples. Type: Expression profiling by high throughput sequencing.
G-rich motifs within phosphorothioate-based antisense oligonucleotides (ASOs) drive activation of FXN expression through indirect effects
GEO Series GSE205526. Homo sapiens. 21 samples. Type: Expression profiling by high throughput sequencing.
CLIP-Seq Analysis Enables the Design of Ribosomal RNA Bait Oligonucleotides That Protect Against C9ORF72 ALS/FTD-Associated Poly-GR Pathophysiology
GEO Series GSE182008. Homo sapiens. 5 samples. Type: Other.
Personalized Antisense Oligonucleotide for A Single Participant With ATN1 Gene Mutation
ClinicalTrials.gov study NCT07084311. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of VEGF-Antisense Oligonucleotide in Combination With Pemetrexed and Cisplatin for the Treatment of Advanced Malignant Mesothelioma
ClinicalTrials.gov study NCT00668499. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Personalized Antisense Oligonucleotide for A Single Participant With GARS1 Gene Mutation Associated With Charcot-Marie-Tooth Disease Type 2D (CMT2D)
ClinicalTrials.gov study NCT07226297. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Personalized Antisense Oligonucleotide Therapy for Rare Pediatric Genetic Disease: SCN2A
ClinicalTrials.gov study NCT06314490. IPD Sharing: NO. Countries: 1. Publications: 0.
Personalized Antisense Oligonucleotide for Participants With CHCHD10 ALS
ClinicalTrials.gov study NCT07095686. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Trial of BP1001 (Liposomal Grb2 Antisense Oligonucleotide) in Combination With Dasatinib in Patients With Ph + CML Who Have Failed TKI, Ph+ AML, Ph+ MDS
ClinicalTrials.gov study NCT02923986. IPD Sharing: NO. Countries: 1. Publications: 0.
Personalized Antisense Oligonucleotide Therapy for a Single Participant with ATN1 Gene Mutation
ClinicalTrials.gov study NCT06706388. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Personalized Antisense Oligonucleotide Therapy for A Single Participant With LMNB1 Mutation Associated Autosomal Dominant Leukodystrophy (ADLD)
ClinicalTrials.gov study NCT06816498. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Personalized Antisense Oligonucleotide Therapy for A Single Participant With TARDBP ALS
ClinicalTrials.gov study NCT07095712. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Personalized Antisense Oligonucleotide for a Single Participant With MAPK8IP3 Neurodevelopmental Disorder With or Without Variable Brain Abnormalities (NEDBA)
ClinicalTrials.gov study NCT07197294. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Antisense Oligonucleotide for Spinal Muscular Atrophy
ClinicalTrials.gov study NCT05187260. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pharmacokinetic Study of Oligonucleotides in Maixuekang Capsules
ClinicalTrials.gov study NCT06823895. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.